1. Home
  2. NYMT vs TYRA Comparison

NYMT vs TYRA Comparison

Compare NYMT & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYMT
  • TYRA
  • Stock Information
  • Founded
  • NYMT 2003
  • TYRA 2018
  • Country
  • NYMT United States
  • TYRA United States
  • Employees
  • NYMT N/A
  • TYRA N/A
  • Industry
  • NYMT Real Estate Investment Trusts
  • TYRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NYMT Real Estate
  • TYRA Health Care
  • Exchange
  • NYMT Nasdaq
  • TYRA Nasdaq
  • Market Cap
  • NYMT 583.3M
  • TYRA 576.6M
  • IPO Year
  • NYMT 2004
  • TYRA 2021
  • Fundamental
  • Price
  • NYMT $6.69
  • TYRA $10.47
  • Analyst Decision
  • NYMT Strong Buy
  • TYRA Strong Buy
  • Analyst Count
  • NYMT 5
  • TYRA 7
  • Target Price
  • NYMT $7.81
  • TYRA $30.86
  • AVG Volume (30 Days)
  • NYMT 647.2K
  • TYRA 364.1K
  • Earning Date
  • NYMT 07-30-2025
  • TYRA 08-06-2025
  • Dividend Yield
  • NYMT 12.03%
  • TYRA N/A
  • EPS Growth
  • NYMT N/A
  • TYRA N/A
  • EPS
  • NYMT N/A
  • TYRA N/A
  • Revenue
  • NYMT $192,556,000.00
  • TYRA N/A
  • Revenue This Year
  • NYMT $6.23
  • TYRA N/A
  • Revenue Next Year
  • NYMT $12.09
  • TYRA N/A
  • P/E Ratio
  • NYMT N/A
  • TYRA N/A
  • Revenue Growth
  • NYMT 14.89
  • TYRA N/A
  • 52 Week Low
  • NYMT $5.02
  • TYRA $6.42
  • 52 Week High
  • NYMT $7.27
  • TYRA $29.60
  • Technical
  • Relative Strength Index (RSI)
  • NYMT 49.08
  • TYRA 58.12
  • Support Level
  • NYMT $6.63
  • TYRA $9.93
  • Resistance Level
  • NYMT $6.79
  • TYRA $10.49
  • Average True Range (ATR)
  • NYMT 0.13
  • TYRA 0.59
  • MACD
  • NYMT -0.01
  • TYRA 0.08
  • Stochastic Oscillator
  • NYMT 57.27
  • TYRA 94.30

About NYMT New York Mortgage Trust Inc.

New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: